Elicio Therapeutics Inc. Cash Flow Quality Index
Elicio Therapeutics Inc. cash flow quality index. Elicio Therapeutics Inc. (ELTX) has a Cash Flow Quality Index of -0.96x as of December 2021. Operating cash flow of $-14.36 Million is below net income of $14.89 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Elicio Therapeutics Inc. to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Elicio Therapeutics Inc. (2012–2013)
Cash flow quality index of Elicio Therapeutics Inc. from 2012 to 2013. Historical Cash Flow Quality Index for Elicio Therapeutics Inc. across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Elicio Therapeutics Inc. (ELTX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Elicio Therapeutics Inc. Cash Flow Quality Index by Year (2012–2013)
Elicio Therapeutics Inc. cash flow quality index by year from 2012 to 2013. Year-by-year earnings quality comparison for Elicio Therapeutics Inc.. For the full cash flow conversion analysis, see Elicio Therapeutics Inc. (ELTX) cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2013 | 2.99x | $1.89 Million | $632.24K | ▼ -13.7% |
| 2012 | 3.47x | $1.07 Million | $307.30K | — |